Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Share-based Compensation (2025)

Updated

Apimeds Pharmaceuticals US (APUS) recorded Share-based Compensation of $1.33 million in Q4 2025.

Analysis

Apimeds Pharmaceuticals US (APUS) Share-based Compensation (2025) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US reported Share-based Compensation of $1.57 million.

  • Across earlier years, Share-based Compensation came in at $69,993 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.81 Mn
Sep 30, 2025 42,674.00
Jun 30, 2025 192,053.00
API Access

Apimeds Pharmaceuticals US Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APUS&period=max&api_key=YOUR_API_KEY